TELMI – AM combines Telmisartan, an angiotensin II receptor blocker (ARB), with Amlodipine, a calcium channel blocker (CCB), offering complementary mechanisms to effectively manage high blood pressure. This combination helps relax blood vessels, improve blood flow, and lower cardiovascular risk.

Key Benefits:

• Enhanced Blood Pressure Control: Dual-action formula reduces blood pressure more effectively than monotherapy.
• Vascular Protection: Prevents blood vessel constriction and improves circulation.
• Cardiovascular Risk Reduction: Lowers the risk of heart attack, stroke, and other.
• complications in hypertensive patients.
• Once-Daily Convenience: Simplifies treatment and improves patient adherence.
• Well-Tolerated: Proven safety profile with minimal side effects.

Indications:

• Hypertension (Primary and Resistant): For patients not adequately controlled with either agent alone.
• Cardiovascular Risk Reduction: In patients with comorbid conditions like diabetes, kidney disease, or high cardiovascular risk
• Stable Angina & Coronary Artery Disease: Supports long-term heart health